Dr. John A Yuhas, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1531 W 32nd St Ste 102, Joplin, MO 64804 Phone: 417-781-3630 Fax: 417-781-9814 |
Dr. Charles F Sherrod Iii, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1531 W 32nd St Ste 102, Joplin, MO 64804 Phone: 417-781-3630 Fax: 417-781-9814 |
Dr. Lance L Brown, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1531 W 32nd St Ste 102, Joplin, MO 64804 Phone: 417-781-3630 Fax: 417-781-9814 |
Trey M Butler, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2700 Mcclelland Blvd, Bldg. C, Suite 304, Joplin, MO 64804 Phone: 417-781-9000 Fax: 417-781-5704 |
Bill Robert Meredith Jr., M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2216 E 32nd St, Ste. 202, Joplin, MO 64804 Phone: 417-782-2020 Fax: 417-782-7861 |
Dr. Curtis Roy Brown, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1531 W 32nd St Ste 102, Joplin, MO 64804 Phone: 417-781-3630 Fax: 417-781-9814 |
Dr. Earl Lawrence Jordan Jr., DO Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2630 Cunningham Ave, Joplin, MO 64804 Phone: 417-781-0044 Fax: 417-781-6331 |
Dr. Herbert K . Dixon, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3201 Mc Intosh Cir, Joplin, MO 64804 Phone: 417-624-8390 Fax: 417-624-8392 |
Dr. Heeral R Shah, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1703 W 30th St, Suite B, Joplin, MO 64804 Phone: 417-781-2616 Fax: 417-781-2934 |
News Archive
Stress affects most Americans at one point or another. Although some people are genetically more susceptible to the stressors of daily life than others, most could benefit from learning how to lower that stress before it negatively affects their physical and mental health.
ALLOZYNE Inc. announced today positive data from preclinical studies evaluating AZ17 which is a novel bispecific Th17 antagonist that inhibits the differentiation and effector function of human Th17 cells in vivo.
Use of cell phones to send images via e-mail to consulting physicians at remote locations appears to be a feasible approach for visualization of chronic leg ulcerations, according to an article in the current issue of Archives of Dermatology.
Neurocrine Biosciences, Inc. announced today that they have established a worldwide collaboration with Boehringer Ingelheim to research and develop small molecule GPR119 agonists for the treatment of Type II diabetes and other indications. The companies will work jointly to identify and advance candidates into pre-clinical development. Boehringer Ingelheim is responsible for the global development and commercialization of potential GPR119 agonist products.
› Verified 8 days ago